Dr. Marchand’s Newest Paper Looks at Novel Uterine Artery Embolization Practices in China

Recently our researchers discovered some very novel practices being undertaken in China, where Uterine Artery Embolization (UAE), which is usually reserved for the treatment of Uterine Fibroids, is being used to treat Cesarean Scar Ectopic Pregnancies (CSP). We assembled the data we could find to offer this interesting look into these novel procedures taking place…

Greg Marchand’s Research on Marijuana in Pregnancy featured in New Report from the Heritage Foundation

The Marchand Institute noted this week a brilliantly written new report “Twenty-First Century Illicit Drugs and Their Discontents: The Potential Risks that Cannabis Use by Pregnant and Nursing Women Pose to Their Children,” by Paul J. Larkin. This report and opinion on the status of cannabis use by pregnant woman addresses a very concerning topic,…

Two of Dr. Marchand’s Research Papers Selected for Oral Presentation at AAGL 2022

We are delighted to announce that two of our research papers, “Meta-Analysis of Veress Needle Entry Versus Direct Trocar Entry in Gynecologic Surgery” and “Meta-Analysis Of Laparoscopic Radical Hysterectomy Vs. Robotic Assisted Radical Hysterectomy For Early Stage Cervical Cancer” have been accepted for oral presentation at the AAGL Global Congress in Aurora, Colorado in December…

New Article Comparing Veress Needle Usage to Direct Trocar Entry

Our newest article gets back to the basics of MIGS with “Systematic review and meta-analysis of Veress needle entry versus direct trocar entry in gynecologic surgery,” which is now available free online at BMJ Surgery, Intervention and Health Technologies.  You can see the full article here:  https://sit.bmj.com/content/4/1/e000121 or read it on the government’s PubMed site…

Marchand Institute, the First Major Research Group to Include Statement of Diversity and Inclusion on All Publications – Now Recommends for All Research Institutions

Since 2019, The Marchand Institute has displayed a paragraph on all publications proudly stating their dedication to diversity, inclusion, and the maintenance of a workplace free of racism and sexism. This declaration, in accordance with our not-for-profit mission for women’s health, is very much a part of what we are as a leading research institute.…